Cargando…
Using Pluripotent Stem Cells to Understand Normal and Leukemic Hematopoietic Development
Several decades have passed since the generation of the first embryonic stem cell (ESC) lines both in mice and in humans. Since then, stem cell biologists have tried to understand their potential biological and clinical uses for their implementation in regenerative medicine. The hematopoietic field...
Autores principales: | Bigas, Anna, Galán Palma, Luis, Kartha, Gayathri M, Giorgetti, Alessandra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9672852/ https://www.ncbi.nlm.nih.gov/pubmed/36398586 http://dx.doi.org/10.1093/stcltm/szac071 |
Ejemplares similares
-
Hematopoietic stem cells from pluripotent stem cells: Clinical potential, challenges, and future perspectives
por: Demirci, Selami, et al.
Publicado: (2020) -
Hematopoietic stem cell‐ and induced pluripotent stem cell‐derived CAR‐NK cells as reliable cell‐based therapy solutions
por: Arias, Jonathan, et al.
Publicado: (2021) -
Pluripotent Stem Cells in Clinical Setting—New Developments and Overview of Current Status
por: Ilic, Dusko, et al.
Publicado: (2022) -
Modeling aortic diseases using induced pluripotent stem cells
por: Zhu, Kai, et al.
Publicado: (2020) -
Neuronal cell‐based medicines from pluripotent stem cells: Development, production, and preclinical assessment
por: Sun, Yun, et al.
Publicado: (2021)